Reiji Fukano
11PUBLICATIONS
35CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (11)
Sort by Publication Date:
|Dec 29, 2025
Phase 1/2 Study of Crizotinib in Children With Relapsed/Refractory ALK-Positive Anaplastic Large Cell Lymphoma or Neuroblastoma in Japan.Tetsuya Mori, Akiko Kada, Tomoo Osumi
|Dec 19, 2023
Rituximab with standard LMB chemotherapy in pediatric high-risk mature B-cell non-Hodgkin lymphoma: A report from the JPLSG B-NHL14 trial.Tetsuya Mori, Tomoo Osumi, Akiko Kada
|Jul 29, 2022
Low NUDT15 expression levels due to biallelic NUDT15 variants and 6-mercaptopurine intolerance.Masanori Yoshida, Scott A Brown, Takaya Moriyama
|Jul 14, 2021
Characteristics of genetic alterations of peripheral T-cell lymphoma in childhood including identification of novel fusion genes: the Japan Children's Cancer Group (JCCG).Kentaro Ohki, Nobutaka Kiyokawa, Satoru Watanabe
|Oct 03, 2020
Alectinib for relapsed or refractory anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: An open-label phase II trial.Reiji Fukano, Tetsuya Mori, Masahiro Sekimizu
Pageof 2
Frequent Collaborators
3 joint publications
Tomoo Osumi
3 joint publications
Ryoji Kobayashi
2 joint publications
Tetsuo Mitsui
2 joint publications
Naoto Fujita
2 joint publications
Yuhki Koga
2 joint publications
Kengo Takeuchi
2 joint publications
Kentaro Ohki
2 joint publications
Tetsuya Mori
1 joint publications
Hiroki Yasudo
1 joint publications
Akira Shimada